Economic Evaluation of Ticagrelor Plus Aspirin Versus Aspirin Alone for Acute Ischemic Stroke and Transient Ischemic Attack

Background: Although ticagrelor plus aspirin is more effective than aspirin alone in preventing the 30-day risk of a composite of stroke or death in patients with an acute mild-to-moderate ischemic stroke (IS) or transient ischemic attack (TIA), the cost-effectiveness of this combination therapy rem...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jigang, Ji, Linjin, Tong, Xin, Han, Mingyang, Zhao, Songfeng, Qin, Yongkai, He, Zilong, Jiang, Zhiqun, Liu, Aihua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8971565/
https://www.ncbi.nlm.nih.gov/pubmed/35370758
http://dx.doi.org/10.3389/fphar.2022.790048

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8971565/
https://www.ncbi.nlm.nih.gov/pubmed/35370758
http://dx.doi.org/10.3389/fphar.2022.790048

Ejemplares similares